Cornea Conditons & Treatments
Corneal Cross – Linking
Collagen Cross-linking has proven to be a first-line treatment for individuals with eye conditions such as keratoconus, pellucid marginal degeneration, and corneal weakness (ectasia) after LASIK. Corneal collagen cross-linking (CXL) has been shown in numerous clinical trials to strengthen the cornea (the clear front surface of the eye) through the application of riboflavin, a form of vitamin B2, followed by treatment with ultraviolet - A light. This procedure is done in our office, without the need for an operating room or general anesthesia. Instead, the eye is numbed using topical drops for a more comfortable experience. Corneal cross-linking can be used in combination with other techniques to treat varying degrees of the condition.
iLink is the only FDA-approved corneal cross-linking procedure for the treatment of progressive keratoconus. This minimally invasive outpatient procedure uses specially formulated prescription eye drops combined with ultraviolet (UV) light from the KXL® System to slow or halt the progression of the disease.
If you have been diagnosed with corneal ectasia or keratoconus call the office to schedule your consultation.